Down syndrome risk calculation for a twin fetus taking account of the nuchal translucency in the co-twin

被引:20
作者
Cuckle, Howard [1 ]
Maymon, Ron [2 ]
机构
[1] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10036 USA
[2] Tel Aviv Univ, Sackler Fac Med, Dept Obstet & Gynecol, Assaf Harofe Med Ctr, IL-69978 Tel Aviv, Israel
关键词
Down syndrome; risk; zygocity; nuchal translucency; correlation; SPONTANEOUSLY CONCEIVED TWINS; IN-VITRO FERTILIZATION; FREE BETA-HCG; ASSISTED REPRODUCTION; MULTIPLE PREGNANCIES; TRANSFUSION SYNDROME; MONOZYGOTIC TWINS; DICHORIONIC TWINS; EMBRYO-TRANSFER; MATERNAL AGE;
D O I
10.1002/pd.2557
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective The objective of this study was to describe and illustrate a method for calculating fetus-specific Down syndrome risk in twins, allowing for between-fetus nuchal translucency (NT) correlation. Methods The between-fetus correlation coefficient of log NT, in multiples of the median, was estimated from a series of 325 unaffected twins after adjustment for sonographer bias. A bivariate log Gaussian model was used to calculate likelihood ratios for discordant and concordant Down syndrome. Applying these to the prior maternal age-specific risk yielded risks in monozygous and dizygous twins. The weighted average risk was then computed with weights relating to chorionicity, gender, assisted reproduction and ethnicity. The method was illustrated using examples. Results The correlation coefficient in unaffected pregnancies was 0.45 (P < 0.0001) and estimated to be 0.12 and 0.04 in discordant and concordant twins, respectively. The examples showed very large differences in the risks obtained when the extent of correlation in NT between fetuses is taken into account and when the measurements are treated as independent. Conclusion Fetus-specific Down syndrome risks in twins should be calculated using its own NT value as well as that of the co-twin. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:827 / 833
页数:7
相关论文
共 38 条
[11]   Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: a prospective randomized clinical trial [J].
Gerris, J ;
De Neubourg, D ;
Mangelschots, K ;
Van Royen, E ;
Van de Meerssche, M ;
Valkenburg, M .
HUMAN REPRODUCTION, 1999, 14 (10) :2581-2587
[12]   First-trimester screening for trisomy 21 in twin pregnancy:: does the addition of biochemistry make an improvement? [J].
Goncé, A ;
Borrell, A ;
Fortuny, A ;
Casals, E ;
Martínez, MA ;
Mercadé, I ;
Cararach, V ;
Vanrell, JA .
PRENATAL DIAGNOSIS, 2005, 25 (12) :1156-1161
[13]  
HEY S, 1970, AM J HUM GENET, V22, P662
[14]   Nuchal translucency in dichorionic twins conceived after assisted reproduction [J].
Hui, PW ;
Tang, MHY ;
Ng, EHY ;
Yeung, WSB ;
Ho, PC .
PRENATAL DIAGNOSIS, 2006, 26 (06) :510-513
[15]   Early first-trimester free β-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins [J].
Linskens, I. H. ;
Spreeuwenberg, M. D. ;
Blankenstein, M. A. ;
van Vugt, J. M. G. .
PRENATAL DIAGNOSIS, 2009, 29 (01) :74-78
[16]   Centre-specific ultrasound nuchal translucency medians needed for Down syndrome screening [J].
Logghe, H ;
Cuckle, H ;
Sehmi, I .
PRENATAL DIAGNOSIS, 2003, 23 (05) :389-392
[17]  
Loos R, 1998, Twin Res, V1, P167, DOI 10.1375/twin.1.4.167
[18]   SOME PERINATAL CHARACTERISTICS OF MONOZYGOTIC TWINS WHO ARE DICHORIONIC [J].
MACHIN, G ;
BAMFORTH, F ;
INNES, M ;
MCNICHOL, K .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 55 (01) :71-76
[19]   Nuchal translucency measurement and pregnancy outcome after assisted conception versus spontaneously conceived twins [J].
Maymon, R ;
Jauniaux, E ;
Holmes, A ;
Wiener, YM ;
Dreazen, E ;
Herman, A .
HUMAN REPRODUCTION, 2001, 16 (09) :1999-2004
[20]   Aneuploidy in twin gestations: When is maternal age advanced? [J].
Meyers, C ;
Adam, R ;
Dungan, J ;
Prenger, V .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (02) :248-251